Target Price | $82.58 |
Price | $71.49 |
Potential |
15.52%
register free of charge
|
Number of Estimates | 12 |
12 Analysts have issued a price target Bio-Techne Corporation 2025 .
The average Bio-Techne Corporation target price is $82.58.
This is
15.52%
register free of charge
$95.00
32.89%
register free of charge
$65.00
9.08%
register free of charge
|
|
A rating was issued by 16 analysts: 12 Analysts recommend Bio-Techne Corporation to buy, 4 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Bio-Techne Corporation stock has an average upside potential 2025 of
15.52%
register free of charge
|
Jun '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion $ | 1.16 | 1.22 |
1.97% | 5.00% | |
EBITDA Margin | 31.47% | 33.98% |
7.79% | 7.97% | |
Net Margin | 14.33% | 14.69% |
41.49% | 2.49% |
13 Analysts have issued a sales forecast Bio-Techne Corporation 2025 . The average Bio-Techne Corporation sales estimate is
This results in the following potential growth metrics:
12 Analysts have issued an Bio-Techne Corporation EBITDA forecast 2025. The average Bio-Techne Corporation EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
6 Bio-Techne Corporation Analysts have issued a net profit forecast 2025. The average Bio-Techne Corporation net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Jun '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share $ | 1.05 | 1.13 |
40.34% | 7.62% | |
P/E | 63.27 | |
EV/Sales | 9.54 |
6 Analysts have issued a Bio-Techne Corporation forecast for earnings per share. The average Bio-Techne Corporation <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is
This results in the following potential growth metrics and future valuations:
Based on analysts' sales estimates for 2025, the Bio-Techne Corporation stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Bio-Techne Corporation...
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.